TRANSDERMAL ESTRADIOL AND CARDIOVASCULAR RISK-FACTORS

[1] ADAMS MR, 1989, TRANSPLANT P, V21, P3662

[2] INHIBITION OF CORONARY-ARTERY ATHEROSCLEROSIS BY 17-BETA ESTRADIOL IN OVARIECTOMIZED MONKEYS - LACK OF AN EFFECT OF ADDED PROGESTERONE [J]. ARTERIOSCLEROSIS, 1990, 10 (06): : 1051 - 1057

[3] ALFIE J, 1993, 7TH INT C MEN STOCKH

[4] ALKJAERSIG N, 1988, J LAB CLIN MED, V111, P224

[5] THE CHRONIC CARDIOVASCULAR RISK FACTOR SYNDROME (SYNDROME-X) - MECHANISMS AND IMPLICATIONS FOR ATHEROGENESIS [J]. POSTGRADUATE MEDICAL JOURNAL, 1991, 67 (792) : 922 - 927

[6] TRANSDERMAL ESTRADIOL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN THE TREATMENT OF MENOPAUSAL COMPLAINTS [J]. DRUGS, 1990, 40 (04) : 561 - 582

[7] BARD JM, 1992, 7TH C EUR ASS GYN OB

[8] POSTMENOPAUSAL ESTROGEN USE AND HEART-DISEASE RISK-FACTORS IN THE 1980S - RANCHO-BERNARDO, CALIF, REVISITED [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (14): : 2095 - 2100

[9] BELJIC T, 1993, 7TH INT C MEN STOCKH

[10] SHORT-TERM AND LONG-TERM EFFECTS OF HORMONE REPLACEMENT THERAPY (TRANSDERMAL ESTRADIOL VS ORAL CONJUGATED EQUINE ESTROGENS, COMBINED WITH MEDROXYPROGESTERONE ACETATE) ON BLOOD-COAGULATION FACTORS IN POSTMENOPAUSAL WOMEN [J]. THROMBOSIS RESEARCH, 1991, 62 (1-2) : 1 - 8

[1] ADAMS MR, 1989, TRANSPLANT P, V21, P3662

[2] INHIBITION OF CORONARY-ARTERY ATHEROSCLEROSIS BY 17-BETA ESTRADIOL IN OVARIECTOMIZED MONKEYS - LACK OF AN EFFECT OF ADDED PROGESTERONE [J]. ARTERIOSCLEROSIS, 1990, 10 (06): : 1051 - 1057

[3] ALFIE J, 1993, 7TH INT C MEN STOCKH

[4] ALKJAERSIG N, 1988, J LAB CLIN MED, V111, P224

[5] THE CHRONIC CARDIOVASCULAR RISK FACTOR SYNDROME (SYNDROME-X) - MECHANISMS AND IMPLICATIONS FOR ATHEROGENESIS [J]. POSTGRADUATE MEDICAL JOURNAL, 1991, 67 (792) : 922 - 927

[6] TRANSDERMAL ESTRADIOL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN THE TREATMENT OF MENOPAUSAL COMPLAINTS [J]. DRUGS, 1990, 40 (04) : 561 - 582

[7] BARD JM, 1992, 7TH C EUR ASS GYN OB

[8] POSTMENOPAUSAL ESTROGEN USE AND HEART-DISEASE RISK-FACTORS IN THE 1980S - RANCHO-BERNARDO, CALIF, REVISITED [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (14): : 2095 - 2100

[9] BELJIC T, 1993, 7TH INT C MEN STOCKH

[10] SHORT-TERM AND LONG-TERM EFFECTS OF HORMONE REPLACEMENT THERAPY (TRANSDERMAL ESTRADIOL VS ORAL CONJUGATED EQUINE ESTROGENS, COMBINED WITH MEDROXYPROGESTERONE ACETATE) ON BLOOD-COAGULATION FACTORS IN POSTMENOPAUSAL WOMEN [J]. THROMBOSIS RESEARCH, 1991, 62 (1-2) : 1 - 8